Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
Phase 1 Clinical Trial to Evaluate the Safety and Exploratory Efficacy of Osteoblast based Cell Therapy CF-M801 derived from Human Umbilical Cord in Patients with Osteonecrosis of the Femoral Head
100 Clinical Results associated with CEFO Co., Ltd.
0 Patents (Medical) associated with CEFO Co., Ltd.
100 Deals associated with CEFO Co., Ltd.
100 Translational Medicine associated with CEFO Co., Ltd.